Safety, Toleration and Efficacy of CP-741,952 for the Treatment of Obesity
NCT00367783
·
clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
100
Enrollment
INDUSTRY
Sponsor class
Stopped
See Detailed Description for termination reason.
Conditions
Obesity
Interventions
DRUG:
CP-741,952
Sponsor
Pfizer